Ekaterina Balaian: Exploring Fostamatinib Use in APS Patients with Thrombocytopenia
Ekaterina Balaian, Clinician Scientist at the University Hospital Dresden, shared on LinkedIn about a recent article she and her colleagues co-authored, adding:
”APS can be a real nightmare in clinical practice. And when it comes with thrombocytopenia, things get even trickier. Too often, we have to rely more on experience and discussion than on solid data regarding anticoagulation.
We gathered some experience in Germany using fostamatinib in APS patients with thrombocytopenia. Based on its proven efficacy in ITP and its potentially favorable profile regarding thrombosis, we explored whether it might help in this particularly challenging setting.
Please, feel free to read about our experience in fresh-out-of-press paper.
A big thank you to all my co-authors for the teamwork, critical thinking, and many thoughtful discussions along the way!”
Title: Fostamatinib treatment for patients with antiphospholipid syndrome and low platelet count: A case series
Authors: Ekaterina Balaian, Rosa Sonja Alesci, Sandra Marten, Julia-Annabell Georgi, Christiane Naue, Martin Bornhäuser, Karolin Trautmann-Grill
Read the Full Article on British Journal of Haematology․
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 16, 2026, 06:58Rob Maloney: From Past to Progress in Hemophilia Care in the Dominican Republic
-
Apr 16, 2026, 06:51Michael Ertl: Patient-Reported Outcomes Reveal Differences in Perceived Stroke Recovery
-
Apr 16, 2026, 06:40Susan Shea: Real-Time Platelet Function Assessment in Trauma Patients
-
Apr 16, 2026, 06:36Alan Nurden: Structural Complexity of Contact Sites within Platelet Aggregates
-
Apr 16, 2026, 06:29Aaron Rodriguez Calienes: Grateful to Receive 2nd Consecutive DeSousa Award in Stroke and Interventional Research
-
Apr 16, 2026, 06:24Paul Bolaji: A Growing Movement to Transform Stroke Care in Africa
-
Apr 16, 2026, 05:22Cedric Hermans: A Simple Way to Stay Updated in Haemophilia and von Willebrand Disease
-
Apr 16, 2026, 04:29Vijay Shah: Increasing Value of AI-Based Assessment in Cardiovascular Risk Prediction
-
Apr 16, 2026, 04:13Mysa Saad: Antiplatelets Increase Bleeding Without Reducing VTE in Cancer Patients